20th International AIDS Conference - Melbourne, Australia


MOSA10 The Hepatitis C Treatment Revolution: Expanding Access to HIV Co-infected and Beyond - Call to Action!
  Non-Commercial Satellite
Venue: Melbourne Room 2
Time: 21.07.2014, 18:30 - 20:30
Chair: Jarbas Barbosa da Silva Junior - Health Surveillance for the Ministry of Health, Brazil, Brazil

Organizer: UNITAID - Médecins Sans Frontières (MSF) - World Health Organization (WHO)
Treatment of Hepatitis C virus (HCV) infection is radically changing with the availability of new, simpler regimens offering improved outcomes and tolerability. Without strategic market interventions, high prices disconnected from production costs will lead to significant time lag between approval and uptake by low- and middle-income countries. This session will 1) explore how low- and middle-income countries have already begun to address HCV disease; 2) describe market barriers to scale up; 3) explore how to address these barriers and; 4) consider the significant opportunities to catalyse the market to enable HCV care and treatment. In particular, speakers will focus on lessons learned during the HIV pandemic to improve access to key diagnostics and treatments, and HIV programmes as an entry point to scale up HCV diagnosis, treatment and care, especially for HIV-HCV co-infected individuals.

This session will interest country HIV programmes, donors, implementers and patient advocates.
18:30

Powerpoint
Global Hepatitis C Guidelines 2014: recommendations for a public health approach
B. Waning - UNITAID, Switzerland
J. Cohn, Switzerland
G. Hirnschall - HIV Department World Health Organization, Switzerland

18:40

Powerpoint
Experiencing HCV infection – the treatment, the reality and the possibilities for cure
E. Agustain - Indonesian Drug Users Network PKNI, Indonesia

18:50

Powerpoint
Hepatitis C diagnostics Technology Landscape
M. Murtagh - UNITAID Consultant, United States

18:55

Powerpoint
Overcoming IP barriers to access generic HCV medicines
L. Menghaney - Médecins Sans Frontières Access Campaign MSF, India

19:00

Powerpoint
Cost drivers for diagnosis and treatment of hepatitis C; options to contain costs
A. Hill - Liverpool University, United Kingdom

19:05

Powerpoint
Programme design to scale up HCV care in resource limited settings
I. Andrieux-Meyer - Médecins Sans Frontières MSF, Switzerland

Powerpoints presentations
Global Hepatitis C Guidelines 2014: recommendations for a public health approach - Brenda Waning - UNITAID
Global Hepatitis C Guidelines 2014: recommendations for a public health approach - Brenda Waning - UNITAID
Global Hepatitis C Guidelines 2014: recommendations for a public health approach - Gottfried Hirnschall - HIV Department World Health Organization

Experiencing HCV infection – the treatment, the reality and the possibilities for cure - Edo Agustain - Indonesian Drug Users Network PKNI

Hepatitis C diagnostics Technology Landscape - Maurine Murtagh - UNITAID Consultant

Overcoming IP barriers to access generic HCV medicines - Leena Menghaney - Médecins Sans Frontières Access Campaign MSF

Cost drivers for diagnosis and treatment of hepatitis C; options to contain costs - Andrew Hill - Liverpool University

Programme design to scale up HCV care in resource limited settings - Isabelle Andrieux-Meyer - Médecins Sans Frontières MSF



   

    The organizers reserve the right to amend the programme.